Cargando…

Patients with Chronic Obstructive Pulmonary Disease and Evidence of Eosinophilic Inflammation Experience Exacerbations Despite Receiving Maximal Inhaled Maintenance Therapy

BACKGROUND: Some patients with chronic obstructive pulmonary disease (COPD) experience frequent exacerbations despite maximal inhaled therapy (“triple therapy”), possibly leading to high health care resource utilization (HCRU). AIM: Describe characteristics, future HCRU, and mortality of patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Stephanie, Miravitlles, Marc, Rhee, Chin Kook, Pavord, Ian D, Jones, Rupert, Carter, Victoria, Emmanuel, Benjamin, Alacqua, Marianna, Price, David B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470244/ https://www.ncbi.nlm.nih.gov/pubmed/36110306 http://dx.doi.org/10.2147/COPD.S378649

Ejemplares similares

Blood eosinophil count predicts treatment failure and hospital readmission for COPD
por: Kerkhof, Marjan, et al.
Publicado: (2020)

Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
por: Siddiqui, Salman H, et al.
Publicado: (2018)

Blood eosinophils to guide inhaled maintenance therapy in a primary care COPD population
por: Ashdown, Helen F., et al.
Publicado: (2021)

The association between eosinophilic exacerbation and eosinophilic levels in stable COPD
por: Kang, Hye Seon, et al.
Publicado: (2021)

Inhaled corticosteroid use by exacerbations and eosinophils: a real-world COPD population
por: Vestbo, Jørgen, et al.
Publicado: (2019)

Human genetics influences microbiome composition involved in asthma exacerbations despite inhaled corticosteroid treatment
por: Perez-Garcia, Javier, et al.
Publicado: (2023)

First maintenance therapy for COPD in the UK between 2009 and 2012: a retrospective database analysis
por: Price, David, et al.
Publicado: (2016)

Blood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPD
por: Pavord, Ian D, et al.
Publicado: (2016)

Factors associated with health status and exacerbations in COPD maintenance therapy with dry powder inhalers
por: W. H. Kocks, Janwillem, et al.
Publicado: (2022)

A randomised controlled trial of small particle inhaled steroids in refractory eosinophilic asthma (SPIRA)
por: Hodgson, David, et al.
Publicado: (2015)

17q21 variant increases the risk of exacerbations in asthmatic children despite inhaled corticosteroids use
por: Farzan, N., et al.
Publicado: (2018)

Comparison of the clinical characteristics and treatment outcomes of patients requiring hospital admission to treat eosinophilic and neutrophilic exacerbations of COPD
por: Kang, Hye Seon, et al.
Publicado: (2016)

Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations
por: Price, David B., et al.
Publicado: (2019)

The sputum transcriptome better predicts COPD exacerbations after the withdrawal of inhaled corticosteroids than sputum eosinophils
por: Ditz, Benedikt, et al.
Publicado: (2021)

A Pooled Analysis of Mortality in Patients with COPD Receiving Dual Bronchodilation with and without Additional Inhaled Corticosteroid
por: Miravitlles, Marc, et al.
Publicado: (2022)

COPD patients prescribed inhaled corticosteroid in primary care: time for re-assessment based on exacerbation rate and blood eosinophils?
por: Savran, Osman, et al.
Publicado: (2021)

Inhaled corticosteroid effects both eosinophilic and non-eosinophilic inflammation in asthmatic patients.
por: Basyigit, Ilknur, et al.
Publicado: (2004)

Blood eosinophils as a biomarker of future COPD exacerbation risk: pooled data from 11 clinical trials
por: Singh, Dave, et al.
Publicado: (2020)

Blood Eosinophil–directed Management of Airway Disease. The Past, Present, and Future
por: Pavord, Ian D.
Publicado: (2020)

Treatment patterns and cost of exacerbations in patients with chronic obstructive pulmonary disease using multiple inhaler triple therapy in South Korea
por: Lee, Chang-Hoon, et al.
Publicado: (2022)

Living without eosinophils: evidence from mouse and man
por: Jackson, David J., et al.
Publicado: (2023)

Association between COPD exacerbations and lung function decline during maintenance therapy
por: Kerkhof, Marjan, et al.
Publicado: (2020)

COPD sputum eosinophils: relationship to blood eosinophils and the effect of inhaled PDE4 inhibition
por: Singh, Dave, et al.
Publicado: (2020)

Dupilumab is effective in type 2‐high asthma patients receiving high‐dose inhaled corticosteroids at baseline
por: Bourdin, Arnaud, et al.
Publicado: (2020)

Relationship Between Changes in Inhalation Treatment Level and Exacerbation of Chronic Obstructive Pulmonary Disease: Nationwide the Health Insurance and Assessment Service Database
por: Jo, Yong Suk, et al.
Publicado: (2020)

Involvement and Possible Role of Eosinophils in Asthma Exacerbation
por: Nakagome, Kazuyuki, et al.
Publicado: (2018)

Moxifloxacin in the management of exacerbations of chronic bronchitis and COPD
por: Miravitlles, Marc
Publicado: (2007)

Maximizing the Outcomes in Cancer Patients Receiving
por: Mucenski, John W., et al.
Publicado: (2003)

Eosinophilic esophagitis: which role for food and inhalant allergens?
por: Ridolo, Erminia, et al.
Publicado: (2012)

Chronic eosinophilic pneumonia: Adjunctive therapy with inhaled steroids
por: Chan, Christopher, et al.
Publicado: (2017)

Rapid effect of benralizumab in exacerbation of severe eosinophilic asthma associated with eosinophilic granulomatosis with polyangiitis
por: Martínez-Rivera, Carlos, et al.
Publicado: (2021)

Exacerbations of COPD
por: Pavord, Ian D, et al.
Publicado: (2016)

The Long-Term Burden of COPD Exacerbations During Maintenance Therapy and Lung Function Decline
por: Kerkhof, Marjan, et al.
Publicado: (2020)

Effects of inhaler therapy on mortality in patients with tuberculous destroyed lung and airflow limitation
por: Kim, Ho Cheol, et al.
Publicado: (2019)

Evaluation of sputum eosinophil count as a predictor of treatment response to mepolizumab
por: Pavord, Ian D., et al.
Publicado: (2022)

Association between plasma interleukin-33 level and acute exacerbation of chronic obstructive pulmonary disease
por: Joo, Hyonsoo, et al.
Publicado: (2021)

Variability of blood eosinophil count and prognosis of COPD exacerbations
por: Martínez-Gestoso, Sandra, et al.
Publicado: (2021)

Unconventional Approach: Steroid Treatment for Eosinophilic Myocarditis Despite Negative Endomyocardial Biopsy
por: Vaysblat, Michael, et al.
Publicado: (2023)

The Importance of Inhaler Adherence to Prevent COPD Exacerbations
por: Jardim, Jose R., et al.
Publicado: (2019)

Blood Eosinophil Depletion with Mepolizumab, Benralizumab, and Prednisolone in Eosinophilic Asthma
por: Moran, Angela M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tee5d4j6hk79u6155p7uiv2pvq